[opensourcepharma] Coverage of Open Source Approaches to Drug Disc/Dev

SHERWOOD NEISS sherwood at theccagroup.com
Sun May 15 14:30:05 UTC 2016

ps - Tomorrow all my work with equity and debt crowdfunding goes live in the USA … so if there are any researchers looking to raise up to $1M in the USA a year and do it online from anyone (despite income or net worth) now is his/her chance!

As co-founders of the Crowdfund Investing movement, CCA uses its unique perspective and methodology to help professional investors and institutions (local, state, national governments and NGO's) build crowdfunding ecosystems to support innovation, strengthen businesses and create thousands of new jobs.

Sherwood Neiss, Principal
Crowdfund Capital Advisors, LLC
Miami . San Francisco . New York . Washington D.C. . Hong Kong . Dubai

Email: sherwood at TheCCAGroup.com <mailto:davis at crowdfundcapitaladvisors.com>
Twitter: @woodien
Web: www.CrowdfundCapitalAdvisors.com <http://www.crowdfundcapitaladvisors.com/> 
Office: (877) 427-2350 x701
Cell:     (202) 247-7182

Latest Contributions:
Venture Beat: 
The SEC’s new 685-page crowdfunding rules: What you need to know <http://venturebeat.com/2015/11/02/the-secs-new-685-page-crowdfunding-rules-what-you-need-to-know/>
U.S. is very late to securities crowdfunding. Can we catch up to the rest of the world? <http://venturebeat.com/2015/10/20/us-is-very-late-to-securities-crowdfunding-can-we-catch-up-to-rest-of-the-world/>
SEC to small business: We’re just not that into you <http://venturebeat.com/2015/01/17/sec-to-small-business-were-just-not-that-into-you/>
Investments in crowdfunding platforms have already doubled this year <http://venturebeat.com/2014/09/08/investments-in-crowdfunding-platforms-have-already-doubled-this-year/>
New bill could finally fix crowdfunding - if the sausage stuffers don’t get to it <http://venturebeat.com/2014/05/08/new-bill-could-finally-fix-crowdfunding-if-the-sausage-stuffers-dont-get-to-it/>
The New York Times thinks only the rich should profit from crowdfunding <http://venturebeat.com/2014/04/09/the-new-york-times-thinks-only-the-rich-should-profit-from-crowdfunding/>
It Might Cost You $39,000 to Crowdfund $100,000 - A Strategy Forward for Entrepreneurs <http://venturebeat.com/2014/01/02/it-might-cost-you-39k-to-crowdfund-100k-under-the-secs-new-rules/>
Crowdfunding report signals increased revenue, jobs, and deal flow <http://venturebeat.com/2014/01/15/crowdfunding-report-signals-increased-revenue-jobs-and-deal-flow/>
How to save crowdfunding before it’s dead on arrival <http://venturebeat.com/2014/02/08/how-to-save-crowdfunding-before-its-dead-on-arrival/>

Interesting Links:
One of Top Ten Most Influential People in Crowdfunding <http://www.forbes.com/sites/chancebarnett/2012/08/16/top-10-most-influential-people-in-business-crowdfunding/>Co-author of the World Bank Report  Crowdfunding's Potential for the Developing world <http://www.infodev.org/crowdfunding>
Co-author of Multilateral Investment Fund Report Creating a Crowdfunding Ecosystem in Chile <http://www.crowdfundinsider.com/2015/07/71477-crowdfund-capital-advisors-works-with-chilean-government-to-foster-crowdfunding-ecosystem/>
Co-author of Crowdfund Investing for Dummies Available at Amazon <http://www.amazon.com/Crowdfund-Investing-Dummies-Sherwood-Neiss/dp/111844969X> & Barnes & Noble <http://www.barnesandnoble.com/listing/2688478933471>   
The Feature Story on Crowdfund Capital Advisors in Entrepreneur Magazine <http://www.entrepreneur.com/article/226741>Co-creator of Success with Crowdfunding <http://www.successwithcrowdfunding.com/>

> On May 13, 2016, at 3:35 AM, Jenny Molloy <jcmcoppice12 at gmail.com> wrote:
> Hi Matt
> Thanks for this round-up and very interesting to read about the MTA. The Biobricks Foundation <http://biobricks.org/> is also working on an Open MTA and I'm involved in that through OpenPlant <http://openplant.org/>, but we're primarily focused on solving issues in synthetic biology and exchange of plasmids, so it'll be interesting to see how the documents compare!
> I will get in touch with the people in the article and report back. Our wording and some info and FAQs will be open for comment and feedback from others very soon.
> Jenny
> On Fri, May 13, 2016 at 1:02 AM, Matthew Todd <mattoddchem at gmail.com <mailto:mattoddchem at gmail.com>> wrote:
> All,
> Lots of well-written coverage today of the work many of us are doing in a special issue of Nature Outlook <http://www.nature.com/nature/outlook/open-innovation/> and, by coincidence, in The Lancet <http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2816%2930518-9/abstract>.
> Also, in case you missed it, Alice Williamson, who works with me here in Sydney on Open Source Malaria, won a competition to make a radio show, in which she describes OSM and other open science issues. You can listen to it on Radio National here <http://www.abc.net.au/radionational/programs/scienceshow/open-source-removes-the-secrecy-in-drug-research/7390322>.
> Please remember - this public list is open to all to post directly, so if you've items you think are of interest, please go right ahead and post (by emailing opensourcepharma at lists.okfn.org <mailto:opensourcepharma at lists.okfn.org>). I liked this recent item <http://www.law.utoronto.ca/news/law-students-redefine-patent-laws-in-clinic-program-structural-genomics-consortium> on an initiative involving the SGC seeking new legal approaches towards MTAs suitable for open projects.
> Best wishes everyone,
> Mat
> -- 
> MATTHEW TODD | Associate Professor
> School of Chemistry | Faculty of Science
> Rm 519, F11 | The University of Sydney | NSW | 2006
> T +61 2 9351 2180 <tel:%2B61%202%209351%202180>  | F +61 2 9351 3329 <tel:%2B61%202%209351%203329>  | M +61 415 274104 <tel:%2B61%20415%20274104>
> E matthew.todd at sydney.edu.au <mailto:matthew.todd at sydney.edu.au> | W http://sydney.edu.au/science/people/matthew.todd.php <http://sydney.edu.au/science/people/matthew.todd.php>
> W http://opensourcemalaria.org/ <http://opensourcemalaria.org/> | W http://opensourcetb.org/ <http://opensourcetb.org/> | W http://opensourcepharma.net/ <http://opensourcepharma.net/>
> CRICOS 00026A
> This email plus any attachments to it are confidential. Any unauthorised use is strictly prohibited. If you receive this email in error, please delete it and any attachments.
> _______________________________________________
> opensourcepharma mailing list
> opensourcepharma at lists.okfn.org <mailto:opensourcepharma at lists.okfn.org>
> https://lists.okfn.org/mailman/listinfo/opensourcepharma <https://lists.okfn.org/mailman/listinfo/opensourcepharma>
> _______________________________________________
> opensourcepharma mailing list
> opensourcepharma at lists.okfn.org
> https://lists.okfn.org/mailman/listinfo/opensourcepharma

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20160515/3cf0ed93/attachment-0002.html>

More information about the opensourcepharma mailing list